Tutorial
RH CHAIN
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Tutorial
01
Overview
02
Follow the Money
03
Daily Brief
04
Live
05
Congress
06
Corporate Insiders
07
Government Money
08
Political Influence
09
Institutions
10
Washington Network
11
Follow the Power
12
Disclosure Clock
13
AI Investigator
14
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Overview
Follow the Money
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Tutorial
Data sources
SEC FORM 4
3m ago
HOUSE PTR
3m ago
SEC 13F
3m ago
ROBINHOOD CHAIN
3m ago
Lobbying registrant
TG
TODD STRATEGY GROUP
Open in network
○
Watch profile
Disclosed transactions
0
Buys / sells
0 / 0
Max Insider Score
—
Connections
24
with evidence
Disclosed transactions
No records
No transactions recorded for this profile.
Verified connections
Lobbied for
evidence
BIODESIX INC
LDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
Lobbied for
evidence
Fox Corp
LDA Q1 2026 first quarter · COM · Aug 26, 2026
Lobbied for
evidence
BIOGEN INC.
LDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
Lobbied for
evidence
PFIZER INC
LDA Q1 2026 first quarter · Pharmacy, TAR, Trade · Aug 26, 2026
Lobbied for
evidence
ELI LILLY & Co
LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
EXELIXIS, INC.
LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid, Copyright/patent · Aug 26, 2026
Lobbied for
evidence
MYRIAD GENETICS INC
LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
BRISTOL MYERS SQUIBB CO
LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
ASTRAZENECA PLC
LDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
Lobbied for
evidence
ALNYLAM PHARMACEUTICALS, INC.
LDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
Merck & Co., Inc.
LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
Guardant Health, Inc.
LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
Lobbied for
evidence
AMGEN INC
LDA Q1 2026 first quarter · Medicare/Medicaid, Health issues, Taxation · Aug 26, 2026
Lobbied for
evidence
MCKESSON CORP
LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
Apollo Global Management, Inc.
LDA Q2 2026 second quarter · Financial institutions · Aug 26, 2026
Lobbied for
evidence
Vaxart, Inc.
LDA Q2 2026 second quarter · MED · Aug 26, 2026
Lobbied for
evidence
GSK plc
LDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
Lobbied for
evidence
CareDx, Inc.
LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
COMPASS Pathways plc
LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
Lobbied for
evidence
Alkermes plc.
LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
Lobbied for
evidence
NOVARTIS AG
LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid, Trade · Aug 26, 2026
Lobbied for
evidence
ILLUMINA, INC.
LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid, Trade · Aug 26, 2026
Lobbied for
evidence
INSULET CORP
LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
Lobbied for
evidence
GILEAD SCIENCES, INC.
LDA Q1 2026 first quarter · Health issues · Aug 26, 2026